NCT02099838View on ClinicalTrials.gov

Effectiveness and Safety of Adding Compound Preparation of Pioglitazone and Metformin for Type 2 Diabetic Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

98

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

Pioglitazone and Metformin

taking 1 tablet twice a day (before breakfast and before dinner) orally for 12 weeks

DRUG

Placebo

taking 1 tablet twice a day (before breakfast and before dinner) orally for 12 weeks

Trial Locations (1)

430030

Tongji Hospital, Wuhan

All Listed Sponsors
collaborator

Wuhan Iron and Steel Workers' Hospital

OTHER

collaborator

Wuhan Pu-Ai Hospital

OTHER

collaborator

Hubei Xinhua Hospital

OTHER

lead

Huazhong University of Science and Technology

OTHER

NCT02099838 - Effectiveness and Safety of Adding Compound Preparation of Pioglitazone and Metformin for Type 2 Diabetic Patients | Biotech Hunter | Biotech Hunter